Citations

Clear

16281 citation(s) found for "Yu, David".

Variability of Computational Fluid Dynamics Solutions for Pressure and Flow in a Giant Aneurysm: The ASME 2012 Summer Bioengineering Conference CFD Challenge
Steinman, David A. , Hoi, Yiemeng , Fahy, Paul, Morris, Liam , Walsh, Michael T. , Aristokleous, Nicolas , Αnayiotos, Αndreas , Papaharilaou, Yannis , Arzani, Amirhossein , Berg, Philipp , Janiga, Gábor , Bols, Joris, Bressloff, Neil W. , Cibiş, Merih , Gijsen, Frank H., Cito, Salvatore , Pallarès, Jordi , Browne, Leonard , Costelloe, J. A., Lynch, Adrian Gerard, Degroote, Joris , Vierendeels, Jan , Fu, Wenyu , Hodis, Simona , Kallmes, David F. , Kalsi, Hardeep S., Long, Quan , Kheyfets, Vitaly O. , Finol, Ender A. , Kono, Kenichi , Malek, Adel M. , Lauric, Alexandra, Menon, Prahlad G. , Pekkan, Kerem , Esmaily, Mahdi , Marsden, Alison L. , Oshima, M. , Katagiri, Kengo, Peiffer, Véronique, Mohamied, Yumnah, Sherwin, Spencer J. , Schaller, J. , Goubergrits, Leonid , Usera, Gabriel , Mendina, Mariana , Valen‐Sendstad, Kristian , Habets, Damiaan F., Xiang, Jianping , Yu, Yue , Karniadakis, George Em , Shaffer, Nicholas, Loth, Francis , Shadden, Shawn C. , Segers, Patrick , Gijsen, Frank , Qiao, Aike , Meng, Hui , Marsden, Alison

Mayo Clinic

Journal of Biomechanical Engineering | January 18, 2013 | Volume: 135 | Issue: 2 | Pages: No page available

10.1115/1.4023382 | PMID 23445061 Get It

Stimulated by a recent controversy regarding pressure drops predicted in a giant aneurysm with a proximal stenosis, the present study sought to assess variability in the prediction of pressures and flow by a wide variety of research groups. In phase I, lumen geometry, flow rates, and fluid properties were specified, leaving each research group to choose their solver, discretization, and solution strategies. Variability was assessed by having each group interpolate their results onto a standardized mesh and centerline. For phase II, a physical model of the geometry was constructed, from which pressure and flow rates were measured. Groups repeated their simulations using a geometry reconstructed from a micro-computed tomography (CT) scan of the physical model with the measured flow rates and fluid properties. Phase I results from 25 groups demonstrated remarkable consistency in the pressure patterns, with the majority predicting peak systolic pressure drops within 8% of each other. Aneurysm sac flow patterns were more variable with only a few groups reporting peak systolic flow instabilities owing to their use of high temporal resolutions. Variability for phase II was comparable, and the median predicted pressure drops were within a few millimeters of mercury of the measured values but only after accounting for submillimeter errors in the reconstruction of the life-sized flow model from micro-CT. In summary, pressure can be predicted with consistency by CFD across a wide range of solvers and solution strategies, but this may not hold true for specific flow patterns or derived quantities. Future challenges are needed and should focus on hemodynamic quantities thought to be of clinical interest.
Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient
Loar, Robert W. , Patterson, Marc C. , Driscoll, David J. , Johnson, Jonathan N. , O’Leary, Patrick , Patterson, Marc

Mayo Clinic

Pediatric Transplantation | January 18, 2013 | Volume: 17 | Issue: 2 | Pages: No page available

10.1111/petr.12039 | PMID 23331314 Get It

AbstractPosterior reversible encephalopathy syndrome (PRES) is a disorder characterized by gray and white matter abnormalities in the temporal, parietal, and occipital lobes of the brain. Its etiology has been attributed to renal failure, immunosuppressive drugs such as cyclosporine and tacrolimus, and other potential entities leading to acute hypertension. Clinical findings include headaches, altered mental status, seizures, visual changes, and focal neurologic deficits. We report the case of a child who developed PRES with intracerebral and subarachnoid hemorrhages associated with tacrolimus exposure 10 days after heart transplantation for restrictive cardiomyopathy. The patient initially presented with complex partial seizures, headache, agitation, and hypertension. Head MRI was suggestive of PRES along with intracerebral and subarachnoid hemorrhages. Tacrolimus was discontinued and blood pressure was controlled. The patient's encephalopathy resolved, but he has had ongoing neurologic symptoms secondary to hemorrhage. Generally, PRES is less common in children than in the adult population and is a rare complication of calcineurin inhibitors (CNI). Presentation with secondary hemorrhage also can occur. In children receiving CNIs presenting with new neurologic symptoms, PRES should be considered as prompt discontinuation of the offending agent can induce resolution of symptoms. Children can develop hemorrhage in the context of PRES, leading to increased morbidity.
Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation
Reddy, Vivek Y. , Doshi, Shephal K. , Sievert, Horst, Buchbinder, Maurice , Neužil, Petr , Huber, Kenneth, Halperin, Jonathan L. , Holmes, David , Huber, Kurt , Huber, Kenneth, Huber, Kurt , Reddy, Vivek Y

Mayo Clinic

Circulation | January 17, 2013 | Volume: 127 | Issue: 6 | Pages: 720-729

10.1161/circulationaha.112.114389 | PMID 23325525 Get It

Background— The multicenter PROTECT AF study (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) was conducted to determine whether percutaneous left atrial appendage closure with a filter device (Watchman) was noninferior to warfarin for stroke prevention in atrial fibrillation. Methods and Results— Patients (n=707) with nonvalvular atrial fibrillation and at least 1 risk factor (age >75 years, hypertension, heart failure, diabetes, or prior stroke/transient ischemic attack) were randomized to either the Watchman device (n=463) or continued warfarin (n=244) in a 2:1 ratio. After device implantation, warfarin was continued for ≈45 days, followed by clopidogrel for 4.5 months and lifelong aspirin. Study discontinuation rates were 15.3% (71/463) and 22.5% (55/244) for the Watchman and warfarin groups, respectively. The time in therapeutic range for the warfarin group was 66%. The composite primary efficacy end point included stroke, systemic embolism, and cardiovascular death, and the primary analysis was by intention to treat. After 1588 patient-years of follow-up (mean 2.3±1.1 years), the primary efficacy event rates were 3.0% and 4.3% (percent per 100 patient-years) in the Watchman and warfarin groups, respectively (relative risk, 0.71; 95% confidence interval, 0.44%–1.30% per year), which met the criteria for noninferiority (probability of noninferiority >0.999). There were more primary safety events in the Watchman group (5.5% per year; 95% confidence interval, 4.2%–7.1% per year) than in the control group (3.6% per year; 95% confidence interval, 2.2%–5.3% per year; relative risk, 1.53; 95% confidence interval, 0.95–2.70). Conclusions— The “local” strategy of left atrial appendage closure is noninferior to “systemic” anticoagulation with warfarin. PROTECT AF has, for the first time, implicated the left atrial appendage in the pathogenesis of stroke in atrial fibrillation. Clinical Trial Registration:— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00129545.
Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction
Samadashvili, Zaza, Walford, Gary, Jacobs, Alice K. , Stamato, Nicholas J., Venditti, Ferdinand J. , Holmes, David R. , Sharma, Samin K. , King, Spencer B., Hannan, Edward L.

Mayo Clinic

Circulation: Cardiovascular Interventions | January 16, 2013 | Volume: 6 | Issue: 1 | Pages: 12-20

10.1161/circinterventions.112.974485 | PMID 23322743 Get It

Background— There are evidence-based guidelines for staging of patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI), but we are not aware of any evidence comparing the strategy of complete revascularization (CR) with PCI in the index admission versus the strategy of staging in a subsequent admission for patients with coronary artery disease without STEMI. Methods and Results— PCI patients without STEMI undergoing PCI in New York between 2007 and 2009 were separated into 2 groups: those with acute coronary syndrome but no STEMI, and those without acute coronary syndrome. For each group, patients who underwent CR in the index admission were then propensity matched to patients staged within 60 days to obtain CR based on 17 patient risk factors related to longer-term mortality, and 3-year mortality rates were compared for the propensity-matched groups. Outcomes were also compared for preselected subgroups. For propensity-matched patients without acute coronary syndrome, the all-cause mortality rates at 3 years for patients who underwent CR in the index hospitalization and patients staged for CR within 60 days of discharge were 5.62% and 5.97%, P =0.93, respectively. For propensity-matched patients with acute coronary syndrome but without STEMI, the all-cause mortality rates at 3 years for patients who underwent CR in the index hospitalization and patients staged for CR within 60 days of discharge were 6.59% and 5.92%, P =0.41, respectively. Conclusions— Patients with coronary artery disease without STEMI do not have significantly lower 3-year mortality rates with staged PCI than when they undergo CR in the index admission.
Endovascular Treatment of Intracranial Aneurysms With Flow Diverters
Brinjikji, Waleed , Murad, M. Hassan , Cloft, Harry J. , Kallmes, David F. , Lanzino, Giuseppe , Murad, M Hassan

Mayo Clinic

Stroke | January 16, 2013 | Volume: 44 | Issue: 2 | Pages: 442-447

10.1161/strokeaha.112.678151 | PMID 23321438 Get It

Background and Purpose— Flow diverters are important tools in the treatment of intracranial aneurysms. However, their impact on aneurysmal occlusion rates, morbidity, mortality, and complication rates is not fully examined. Methods— We conducted a systematic review of the literature searching multiple databases for reports on the treatment of intracranial aneurysms with flow-diverter devices. Random effects meta-analysis was used to pool outcomes of aneurysmal occlusion rates at 6 months, and procedure-related morbidity, mortality, and complications across studies. Results— A total of 29 studies were included in this analysis, including 1451 patients with 1654 aneurysms. Aneurysmal complete occlusion rate was 76% (95% confidence interval [CI], 70%–81%). Procedure-related morbidity and mortality were 5% (95% CI, 4%–7%) and 4% (95% CI, 3%–6%), respectively. The rate of postoperative subarachnoid hemorrhage was 3% (95% CI, 2%–4%). Intraparenchymal hemorrhage rate was 3% (95% CI, 2%–4%). Perforator infarction rate was 3% (95% CI, 1%–5%), with significantly lower odds of perforator infarction among patients with anterior circulation aneurysms compared with those with posterior circulation aneurysms (odds ratio, 0.01; 95% CI, 0.00–0.08; P <0.0001). Ischemic stroke rate was 6% (95% CI, 4%–9%), with significantly lower odds of perforator infarction among patients with anterior circulation aneurysms compared with those with posterior circulation aneurysms (odds ratio, 0.15; 95% CI, 0.08–0.27; P <0.0001). Conclusions— This meta-analysis suggests that treatment of intracranial aneurysms with flow-diverter devices is feasible and effective with high complete occlusion rates. However, the risk of procedure-related morbidity and mortality is not negligible. Patients with posterior circulation aneurysms are at higher risk of ischemic stroke, particularly perforator infarction. These findings should be considered when considering the best therapeutic option for intracranial aneurysms.
Harry Lee Parker and paroxysmal dysarthria and ataxia
Klaas, James P. , Burkholder, David B. , Singer, Wolfgang , Boes, Christopher J. , Burkholder, David B

Mayo Clinic

Neurology | January 14, 2013 | Volume: 80 | Issue: 3 | Pages: 311-314

10.1212/wnl.0b013e31827dec0f | PMID 23319475 Get It

Faculty Opinions recommendation of Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
Katzka, David A.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 14, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717961987.793468751 Get It

Faculty Opinions recommendation of Subjective and objective data on esophageal manometry and impedance pH monitoring 1 year after endoscopic full-thickness plication for the treatment of GERD by using multiple plication implants.
Katzka, David A.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 14, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717962026.793468754 Get It

Commentary on “Laparoscopic Retroperitoneal Dismembered Pyeloplasty: Single-Center Experience in China”
Thiel, David D.

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | January 14, 2013 | Volume: 23 | Issue: 1 | Pages: 42-42

10.1089/lap.2012.9985 | PMID 23317440 Get It

Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease
Ackerman, Michael J. , Cannon, Bryan C. , Corrado, Domenico , Heidbüchel, Hein , Prutkin, Jordan M. , Salerno, Jack C., Anderson, Jeffrey A., Ashley, Euan A. , Asplund, Chad A., Baggish, Aaron L. , Börjesson, Mats , DiFiori, John P. , Fischbach, Peter , Froelicher, Victor F. , Marek, Joseph C., Owens, David S. , Paul, Stephen , Pelliccia, Antonio , Schmied, Christian , Sharma, Sanjay , Vetter, Victoria L. , Wilson, Mathew G , Drezner, Jonathan A. , Harmon, Kimberly G. , Sharma, Sanjay , Stein, Ricardo , Baggish, Aaron L

Mayo Clinic

British Journal of Sports Medicine | January 9, 2013 | Volume: 47 | Issue: 3 | Pages: 153-167

10.1136/bjsports-2012-092070 | PMID 23303761 Get It

Cardiac channelopathies are potentially lethal inherited arrhythmia syndromes and an important cause of sudden cardiac death (SCD) in young athletes. Other cardiac rhythm and conduction disturbances also may indicate the presence of an underlying cardiac disorder. The 12-lead ECG is utilised as both a screening and a diagnostic tool for detecting conditions associated with SCD. Fundamental to the appropriate evaluation of athletes undergoing ECG is an understanding of the ECG findings that may indicate the presence of a pathological cardiac disease. This article describes ECG findings present in primary electrical diseases afflicting young athletes and outlines appropriate steps for further evaluation of these ECG abnormalities. The ECG findings defined as abnormal in athletes were established by an international consensus panel of experts in sports cardiology and sports medicine.